Molecular Partners Ag MOLN
NASDAQ MOLN
$4.40 +0.17 (+4.04%)
As of: Aug 21, 2026 · 12:43 PM EDT

Molecular Partners Ag (MOLN) EBT Margin Growth (1y) (2021 - 2026)

Molecular Partners Ag (MOLN) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.90 Bn 131.05 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 86.10 Bn 78.11 Bn 3.93 Bn -571.00
3 Argenx Se 65.56 Bn 60.37 Bn 1.37 Bn 546.00
4 Moderna 55.82 Bn 50.68 Bn 52.00 Mn 4,709.00
5 BeOne Medicines 42.14 Bn 37.04 Bn 1.53 Bn 1,076.00
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 1,911.00
7 BioNTech SE 27.74 Bn 9.35 Bn 668.28 Mn -2,507.00
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn 29,565.00
9 Royalty Pharma 27.38 Bn 26.54 Bn - -392.00
10 Molecular Partners Ag 163.99 Mn 163.99 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 613.00
Dec 31, 2025 -95.36 Mn
Sep 30, 2025 -9,826.00
Jun 30, 2025 97.23 Mn
Mar 31, 2025 30,972.00
Dec 31, 2024 109.85 Mn
Sep 30, 2024 45,017.00
Jun 30, 2024 -96.86 Mn
Mar 31, 2024 -41,362.00
Dec 31, 2023 -99,130.00
Sep 30, 2023 -45,018.00
Jun 30, 2023 -381,383.00
Mar 31, 2023 0.00
Dec 31, 2022 8,132.00
Sep 30, 2022 34,840.00
Jun 30, 2022 -4,189.00
Mar 31, 2022 0.00
Dec 31, 2021 -2.00
Sep 30, 2021 -34,841.00